Vancouver, Canada

Burkhard Jansen


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • La Jolla, CA (US) (2010 - 2011)
  • Vancouver, CA (2007 - 2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Burkhard Jansen: Innovator in RNAi Therapeutics

Introduction

Burkhard Jansen is a prominent inventor based in Vancouver, Canada, known for his significant contributions to the field of RNA interference (RNAi) therapeutics. With a total of nine patents to his name, Jansen has focused on developing innovative solutions for treating various types of cancers and Alzheimer's disease.

Latest Patents

Jansen's latest patents include RNAi probes targeting cancer-related proteins. These RNAi sequences are designed to serve as therapeutics in the treatment of multiple cancers, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma, and melanoma. The sequences specifically target proteins such as clusterin, IGFBP-5, IGFBP-2, Mitf, and B-raf. Furthermore, the invention outlines a method for treating these conditions through the administration of RNA molecules with RNAi activity to individuals in need of such treatment.

Career Highlights

Throughout his career, Burkhard Jansen has worked with notable institutions, including the University of British Columbia and Novelix Pharmaceuticals, Inc. His work has significantly advanced the understanding and application of RNAi technology in therapeutic settings.

Collaborations

Some of Jansen's notable coworkers include Martin E. Gleave and Ioannis P. Trougakos, who have collaborated with him on various research projects and innovations.

Conclusion

Burkhard Jansen's contributions to RNAi therapeutics have the potential to revolutionize the treatment of cancer and Alzheimer's disease. His innovative work continues to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…